Hs. Xie et Ww. Lautt, INDUCTION OF INSULIN-RESISTANCE BY CHOLINERGIC BLOCKADE WITH ATROPINEIN THE CAT, Journal of autonomic pharmacology, 15(5), 1995, pp. 361-369
1 Insulin sensitivity was quantified using a modified euglycaemic tech
nique after hepatic cholinergic blockade with atropine and compared wi
th that after surgical denervation. 2 Intraportal administration of at
ropine produced dose-dependent inhibition of insulin sensitivity in gl
ucose metabolism. ED(50) of atropine was 0.99 mg kg(-1) (1 mg = 1.5 mu
M) with maximum inhibition of 40.3 +/- 11.6%. 3 Atropine (3 mg kg(-1)
) reduced insulin sensitivity by a similar amount (33.6 +/- 3.4%) to t
hat produced by hepatic surgical denervation (37.8 +/- 9.8%). Doses gr
eater than 3 mg kg(-1) failed to further alter the insulin resistance
produced by surgical denervation or atropine (3 mg kg(-1)) administrat
ion, suggesting that activation of hepatic parasympathetic nerves is n
ecessary to fully express the insulin effect. 4 Atropine reduced insul
in sensitivity without changes in plasma concentrations of glucagon or
insulin. The temporal response to insulin in this euglycaemic study w
as not changed after atropine administration or after surgical hepatic
denervation. 5 It is suggested that hepatic parasympathetic nerves sh
ow a synergistic effect with insulin. Disease states that result in he
patic parasympathetic neuropathy would be expected to produce an insul
in resistant liver. 6 The modified euglycaemic clamp method for assess
ing insulin responses was shown to be reproducible up to four times in
the same animal and was sufficiently sensitive and quantitative to be
able to generate a dose-response curve in each animal for atropine-in
duced insulin resistance.